GPIIB/IIIA ANTAGONISTS WITH LONG ORAL DURATION

被引：0

作者：

SAMANEN, J ^{[1
]}

ALI, F ^{[1
]}

BARTON, L ^{[1
]}

BONDINELL, W ^{[1
]}

BURGESS, J ^{[1
]}

CALLAHAN, J ^{[1
]}

CALVO, R ^{[1
]}

CHEN, L ^{[1
]}

ERHARD, K ^{[1
]}

HWANG, SM ^{[1
]}

JAKAS, D ^{[1
]}

KEENAN, R ^{[1
]}

KU, T ^{[1
]}

KWON, C ^{[1
]}

LEE, CP ^{[1
]}

MILLER, W ^{[1
]}

NEWLANDER, K ^{[1
]}

NICHOLS, A ^{[1
]}

PARKER, M ^{[1
]}

PEISHOFF, C ^{[1
]}

RHODES, G ^{[1
]}

ROSS, S ^{[1
]}

SIMPSON, R ^{[1
]}

TAKATA, D ^{[1
]}

YELLIN, TO ^{[1
]}

UZSINSKAS, I ^{[1
]}

VENSLAVSKY, J ^{[1
]}

YUAN, CY ^{[1
]}

HUFFMAN, W ^{[1
]}

机构：

[1] SMITHKLINE BEECHAM PHARMACEUT,KING OF PRUSSIA,PA 19406

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 1995年 / 209卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

引用

页码：237 / MEDI

共 50 条

[31] Role of extracellular ionized calcium in the in vitro assessment of GPIIb/IIIa receptor antagonists
Rebello, SS
Huang, J
Faul, JD
Lucchesi, BR
JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2000, 9 (01) : 23 - 28
[32] Platelet GPIIb/IIIa antagonists: The first anti-integrin receptor therapeutics
Coller, BS
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (11): : S57 - S60
[33] Elevating local concentrations of GPIIb–IIIa antagonists counteracts platelet thrombus stability
Henry E. Speich
Ronit R. Furman
Lindsey T. Lands
Geoffrey D. Moodie
Lisa K. Jennings
Journal of Thrombosis and Thrombolysis, 2013, 36 : 31 - 41
[34] Role of Extracellular Ionized Calcium in the In Vitro Assessment of GPIIb/IIIa Receptor Antagonists
Sam S. Rebello
Jinbao Huang
Jessica D. Faul
Benedict R. Lucchesi
Journal of Thrombosis and Thrombolysis, 2000, 9 : 23 - 28
[35] Platelet GPIIb/IIIa antagonists: The first anti-integrin receptor therapeutics
Coller, BS
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (07): : 1467 - 1471
[36] Antiplatelet therapies: from aspirin to GPIIb/IIIa-receptor antagonists and beyond
Mousa, SA
DRUG DISCOVERY TODAY, 1999, 4 (12) : 552 - 561
[37] Platelet glycoprotein IIb-IIIa receptor (GPIIb-IIIa) antagonists derived from amidinoindoles.
Sall, DJ
Arfsten, AE
Berry, DR
Denney, ML
Harms, CS
McCowan, JR
Ray, JK
Scarborough, RM
Um, SL
Utterback, BG
Jakubowski, JA
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (01) : 81 - 86
[38] CHARACTERIZATION OF THE ANTIPLATELET EFFECTS OF GPIIB/IIIA FIBRINOGEN RECEPTOR ANTAGONISTS (FRA) IN ANESTHETIZED BABOONS
SCHAFFER, L
DAVIDSON, J
GOULD, R
GARSKY, V
LUMMA, P
HARTMAN, G
BRADY, S
NUTT, R
SIEGL, P
FASEB JOURNAL, 1993, 7 (04): : A564 - A564
[39] Elevating Local Concentrations of GPIIb-IIIa Antagonists Intensifies Platelet Thrombus Instability
Speich, Henry E.
Lands, Lindsey T.
Furman, Ronit R.
Moodie, Geoffrey D.
Jennings, Lisa K.
CIRCULATION, 2011, 124 (21)
[40] Effect of anticoagulation and platelet agonist concentration on the inhibitory activities of GPIIb-IIIa antagonists
Nannizzi-Alaimo, L
Rychel, AL
Teng, W
Clizbe, LA
Seroogy, JJ
Scarborough, RM
Phillips, DR
CIRCULATION, 1999, 100 (18) : 710 - 710

← 1 2 3 4 5 →